Kailos Genetics, LLC. services

Kailos Genetics combines robust next generation sequencing with illuminating, high-powered analytics to produce accurate and comprehensive genetic information. We pride ourselves on outstanding customer support with rapid turnaround times and seamless information delivery. Kailos has over a decade of experience in genetic analysis utilizing our in-house, proprietary clinical assays and analytical software. Our highly qualified laboratory and analytics teams use next generation sequencing for all of our tests and design only clinical grade assays to provide actionable results for your clients.

Designed around evidence-based guidelines and recommendations from leading genetic healthcare experts, Kailos Prevent™ can identify DNA changes with significant potential for positive impact on a person`s health. These genetic changes increase the risk of developing cancer, heart disease, strokes and the metabolism of antidepressants & opioids.

Genetic variations screened in the Expedio Hereditary Cancer Screening Service are associated with an increased risk of developing breast, endocrine, gastrointestinal, genitourinary, gynecologic, hematologic, nervous system, soft tissue, bone, and/or skin cancers.